This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Orphan designation: Elraglusib Treatment of pancreatic cancer, 16/01/2025 Positive
Orphan designation: Alvelestat Treatment of congenital alpha-1 antitrypsin defic...
Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2...
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, ...
Data Analysis and Real World Interrogation Network (DARWIN EU)
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, ...
DARWIN EU: Making health data count
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab,...
DARWIN EU data partners onboarded in phases I and II
DARWIN EU Advisory Board meeting: 3 May 2024, Online, European Medicines Agency,...
Minutes - DARWIN EU Advisory Board - 3 May 2024
Human medicines European public assessment report (EPAR): Qaialdo, spironolacton...
Human medicines European public assessment report (EPAR): Memantine Mylan, meman...
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, D...
Opinion/decision on a Paediatric investigation plan (PIP): Feraccru, ferric malt...
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Dat...
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (17...